PFND logo

Pathfinder Cell Therapy, Inc. Stock Price

OTCPK:PFND Community·US$667.0 Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

PFND Share Price Performance

US$0.000001
0.00 (0.00%)
US$0.000001
0.00 (0.00%)
Price US$0.000001

PFND Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

Pathfinder Cell Therapy, Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$1.1m

Other Expenses

-US$1.1m

Earnings

Last Reported Earnings
Sep 30, 2015
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About PFND

Founded
2008
Employees
n/a
CEO
Richard Franklin
WebsiteView website
www.pathfindercelltherapy.com

Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage. It identifies diabetes, renal disease, myocardial infarction, peripheral vascular disease, and other diseases as potential indications for therapies based on its technology. The company was founded in 2008 and is headquartered in Cambridge, Massachusetts.

Recent PFND News & Updates

No updates

Recent updates

No updates